This statistic displays the top 10 changes in market capitalizations of biotechnology companies in the United States between 2012 and 2016 . During this period , Amgen had an increase in market capitalization of nearly 58 billion U.S. dollars . Revenues of the United States biotechnology market has grown over the last 15 years .
